DCAPI1553 |
Pyrimethamine |
Pyrimethamine is a potent inhibitor of multi-drug and toxin extrusion transporters. This compound inhibits Mdr-1(Pgp) and thus allows for active drugs to stay within the cell for longer periods of time, increasing their effectiveness by preventing efflux |
|
DC7664 |
Quarfloxin (CX-3543)
Featured
|
Quarfloxin (CX-3543) is a fluoroquinolone derivative with antineoplastic activity. |
|
DC5197 |
Quizartinib (AC220)
Featured
|
Quizartinib (AC220) is a second-generation FLT3 inhibitor for Flt3(ITD/WT) with IC50 of 1.1 nM/4.2 nM, 10-fold more selective for Flt3 than KIT, PDGFRα, PDGFRβ, RET, and CSF-1R. Phase 1/2. |
|
DC11138 |
Guanabenz acetate |
R15A inhibitor. |
|
DC2068 |
R547 |
R547 is a potent and selective CDK inhibitor with Ki and IC50 of 1-3 nM and 80 nM respectively. |
|
DC9462 |
R-7128(Mericitabine)
Featured
|
R-7128(Mericitabine) is a selective nucleoside analog inhibitor of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase, with activity across all HCV genotypes.
|
|
DC9841 |
Fostamatinib(R788)
Featured
|
R788 (Fostamatinib), a prodrug of the active metabolite R406, is a potent Syk inhibitor with IC50 of 41 nM. |
|
DC1013 |
R788 disodium (Fostamatinib)
Featured
|
R935788 (Fostamatinib disodium, R788) is a Syk inhibitor with IC50 of 41 nM. |
|
DC9513 |
Radafaxine (hydrochloride)
Featured
|
Radafaxine Hcl(BW-306U; GW-353162A) is a potent metabolite of bupropion; selective for inhibiting the reuptake of norepinephrine over dopamine; DAT (dopamine transporter) and NET(norepinephrine transporter) transporters inhibitor, and nAChR family modulat |
|
DC5049 |
RAF265 (CHIR-265)
Featured
|
RAF265 (CHIR-265) is a highly selective B-Raf and VEGFR2 inhibitor with IC50 of 3-60 nM and EC50 of 30 nM, including B-Raf, C-Raf and mutant B-Raf. |
|
DC8930 |
Rafoxanide |
Rafoxanide is a salicylanilide used as an antiparasitic agent. |
|
DC9479 |
Raltegravir (potassium salt) |
Raltegravir potassium salt(MK0518 potassium salt) is a potent integrase (IN) inhibitor, used to treat HIV infection.
|
|
DCAPI1581 |
Raltegravir
Featured
|
Raltegravir Salt is a potent human immunodeficiency virus (HIV) integrase inhibitor and a novel anti-AIDS drug. |
|
DC8940 |
Raltitrexed
Featured
|
Raltitrexed(ZD1694), an inhibitor of thymidylate synthase, is an antimetabolite drug used in cancer chemotherapy. |
|
DC9162 |
Ranolazine HCl
Featured
|
Ranolazine(RS-43285) is an antianginal agent with antiarrhythmic properties that achieves its effects via a novel mechanism of action (inhibition of the late phase of the inward sodium current), without affecting heart rate or blood pressure (BP). |
|
DC1048 |
Rapamycin (Sirolimus)
Featured
|
Rapamycin (Sirolimus, AY-22989, WY-090217) is a specific mTOR inhibitor with IC50 of ~0.1 nM. - |
|
DC8175 |
Rapastinel(GLYX-13)
Featured
|
Rapastinel(GLYX-13) is a NMDA receptor partial agonist that acts at the glycine site. |
|
DC8190 |
Ravidasvir hydrochloride (PPI-668)
Featured
|
Ravidasvir(PPI-668) is a NS5A Inhibitor. |
|
DC7808 |
Refametinib (BAY86-9766)
Featured
|
Refametinib (RDEA119, Bay 86-9766) is a potent, ATP non-competitive and highly selective inhibitor of MEK1 and MEK2 with IC50 of 19 nM and 47 nM, respectively. |
|
DC9777 |
Regorafenib monohydrate(BAY 73-4506)
Featured
|
Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM, respectively. |
|
DC1030 |
Regorafenib (BAY73-4506,Fluoro-Sorafenib)
Featured
|
Regorafenib (BAY 73-4506, Fluoro-Sorafenib) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM, respectively. |
|
DC10441 |
Relebactam
Featured
|
Relebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases, including class A (extended-spectrum β-lactamases [ESBLs] and KPC) and class C (AmpC) enzymes. |
|
DC10463 |
Repotrectinib(TPX-005)
Featured
|
Repotrectinib(TPX-005) is a multi-target macrocycle inhibitor of anaplastic lymphoma kinase (ALK), c-ros proto-oncogene 1 receptor tyrosine kinase (ROS1), and neurotrophic tyrosine kinase receptor (TRK) |
|
DC7261 |
Resminostat hydrochloride (4SC-201) |
Resminostat(RAS2410; 4SC-201) is a potent inhibitor of HDAC1/3/6(IC50=43-72 nM); less potent to HDAC8 with IC50 of 877 nM. |
|
DC4148 |
Retapamulin |
Retapamulin is a topical antibiotic, which binds to both E. coli and S. aureus ribosomes with similar potencies with Kd of 3 nM. |
|
DC10191 |
RG7800 |
RG7800 a small molecule SMN2 splicing modifier to enter human clinical trials to treat spinal muscular atrophy. |
|
DC8185 |
Verosudil(AR-12286) |
Rho-kinase (ROCK) inhibitor |
|
DCAPI1165 |
Ribavirin (Copegus)
Featured
|
Ribavirin is a guanosine analog with antiviral properties against DNA and RNA viruses, including respiratory syncytial virus, hepatitis C, and influenza. |
|
DCAPI1325 |
Rifabutin (Mycobutin) |
Rifabutin (Mycobutin) |
|
DC7265 |
Rigosertib
Featured
|
Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM; shows 30-fold greater selectivity against PLK2 and no activity to PLK3. |
|